Marco Gross-Langenhoff

Marco Gross-Langenhoff is a seasoned professional in health economics and outcomes research, currently serving as the Global HEOR Lead for Oncology at Astellas Pharma since December 2009. In this role, Marco oversees the development and delivery of health economic data, real-world evidence, and health technology assessments. Additional responsibilities include serving in a part-time secondment supporting early-stage medical affairs for oncology assets, leading regional HEOR strategies in Europe and Canada, and managing medical affairs for oncology and urology in Germany and Austria. Marco has also contributed to various professional organizations, including ISPOR and EFPIA, and holds a Ph.D. in Pharmaceutical Biochemistry from the University of Tübingen, along with several other advanced degrees in pharmacy, economics, and health technology assessment.